Showing results (41-50 of 3,623) with videos related to

Sort By:
Pageof 363
Circulation Research|April 3, 2001
Retinoids inhibit the actions of angiotensin II on vascular smooth muscle cellsV Haxsen, S Adam-Stitah, E Ritz, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 1997
Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells?K Amann, B Wolf, C Nichols, et al.
Pflugers Archiv : European Journal of Physiology|June 1, 1995
Decreased renal haemodynamic response to inhibition of nitric oxide synthase in subtotally nephrectomized ratsJ Wagner, A Wystrychowski, H Stauss, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 1, 1988
The spectrum of renal involvement in epidermolysis bullosa dystrophica hereditaria: report of two casesJ F Mann, M Zeier, E Zilow, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 1, 1996
Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablationA Nabokov, K Amann, J Wagner, et al.
Hormone Research|November 19, 2002
Risk of mortality in patients with end-stage renal disease: the role of malnutrition and possible therapeutic implicationsM Zeier
Journal of the American Society of Nephrology : JASN|January 1, 1995
Renin gene expression in human kidney biopsies from patients with glomerulonephritis or graft rejectionJ Wagner, S Volk, C C Haufe, et al.
Kidney International|February 13, 1999
Endothelin receptor antagonists influence cardiovascular morphology in uremic ratsA V Nabokov, K Amann, S Wessels, et al.
Kidney International|December 1, 1994
PCR analysis of human renal biopsies--renin gene regulation in glomerulonephritisJ Wagner, M Drab, F Gehlen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 27, 1999
Treatment of cardiovascular changes in renal failure--ACE inhibition, endothelin receptor blockade or a combination of both strategies?K Amann, K Münter, J Wagner, et al.
Pageof 363